Cutler Group LP Assembly Biosciences, Inc. Put Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 Apr 26, 2021	SELL	$4.33 - $6.63 $2,165 - $3,315	-500 Reduced 50.0%	500 $0
Q4 2020 Jan 21, 2021	SELL	$4.87 - $17.29 $23,376 - $82,992	-4,800 Reduced 82.76%	1,000 $0
Q1 2020 May 07, 2020	BUY	$10.27 - $21.23 $57,512 - $118,888	5,600 Added 2800.0%	5,800 $32,000
Q3 2019 Oct 28, 2019	BUY	$9.83 - $14.82 $983 - $1,482	100 Added 100.0%	200 $0
Q2 2019 Aug 09, 2019	SELL	$12.9 - $20.8 $18,060 - $29,120	-1,400 Reduced 93.33%	100 $0
Q1 2019 May 10, 2019	SELL	$17.7 - $24.93 $115,050 - $162,045	-6,500 Reduced 81.25%	1,500 $0
Q4 2018 Feb 05, 2019	BUY	$19.05 - $36.45 $127,635 - $244,215	6,700 Added 515.38%	8,000 $82,000
Q2 2018 Aug 10, 2018	BUY	$39.21 - $50.29 $39,210 - $50,290	1,000 Added 333.33%	1,300 $13,000
Q1 2018 May 11, 2018	SELL	$41.7 - $64.16 $91,740 - $141,152	-2,200 Reduced 88.0%	300 $1,000
Q3 2017 Oct 17, 2017	BUY	$23.08 - $34.92 $57,699 - $87,300	2,500	2,500 $1,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $723M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.